Meeting the diverse demands of different consumer populations that span generations can be a challenge. This white paper explores the scientific background and 5-in-1 health benefits of ANKASCIN® 568, an FDA NDI-approved fermented botanical known for improving metabolic health and aiding healthy aging. It also provides market insights and custom-made recommendations for combining ANKASCIN® 568 with components such as omega-3 fatty acids, berberine, magnesium, chromium, Garcinia, and vitamin D to boost your product’s market appeal with ANKASCIN® 568 advantages. Let ANKASCIN® 568 and our expert solutions elevate your product to new heights!
The Link Between Immune Health Benefits & Healthy, Active Lifestyles
January 11th 2024Better immune health means more healthy, active days – and who doesn’t want that? Now, we’re in an era where consumers want to be proactive about their immune health. Nutritional Outlook’s latest podcast highlights one key immune health ingredient, IMMUSE™, that brings a unique mode of action to activate pDCs (plasmacytoid dendritic cells)* — a pivotal leader within the immune system.
What Today’s Cognitive Health Consumers are Focusing On
January 10th 2024Nootropics have become a buzzword in the supplement space, and formulators are faced with a number of different ingredient options to use in their next formulation. In this podcast, Nutritional Outlook explores a clinically researched brain health ingredient, Cognizin® Citicoline, that can help supply the required nutrition that the brain needs to stay focused and alert all day long.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market (September 2024)
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.